CLINICAL_TRIALS
trial_result
· 2024-12-06
Clinical Trial Update: Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis [Phase 2, Phase 3]
Summary
Phase 2/3 trial of ravulizumab versus placebo in adults with dermatomyositis was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Dermatomyositis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-12-06